MSH Capital Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
3,997
+247
+7% +$91.5K 0.29% 89
2026
Q1
$1.01M Buy
3,750
+224
+6% +$66.7K 0.21% 109
2025
Q4
$1.16M Buy
3,526
+163
+5% +$55.2K 0.25% 101
2025
Q3
$1.16M Buy
3,363
+131
+4% +$39.6K 0.31% 85
2025
Q2
$1.01M Buy
3,232
+2,307
+249% +$882K 0.29% 96
2025
Q1
$484K Sell
925
-17
-2% -$8.69K 0.15% 154
2024
Q4
$476K Sell
942
-67
-7% -$38.1K 0.15% 157
2024
Q3
$590K Sell
1,009
-26
-3% -$14.7K 0.18% 130
2024
Q2
$527K Sell
1,035
-155
-13% -$76K 0.18% 126
2024
Q1
$589K Hold
1,190
0.21% 113
2023
Q4
$626K Sell
1,190
-145
-11% -$77.3K 0.23% 106
2023
Q3
$673K Sell
1,335
-67
-5% -$33K 0.26% 104
2023
Q2
$674K Buy
1,402
+262
+23% +$128K 0.25% 106
2023
Q1
$539K Buy
1,140
+1
+0.1% +$483 0.23% 108
2022
Q4
$604K Buy
1,139
+35
+3% +$18.5K 0.27% 103
2022
Q3
$557K Buy
1,104
+2
+0.2% +$1.05K 0.27% 95
2022
Q2
$566K Sell
1,102
-225
-17% -$113K 0.26% 99
2022
Q1
$677K Buy
1,327
+506
+62% +$244K 0.28% 95
2021
Q4
$412K Buy
+821
New +$372K 0.18% 118

Other funds holding UNH

MSH Capital Advisors's UNH Position: Q2 2026 in Review

MSH Capital Advisors increased its UnitedHealth (UNH) stake by 6.6% in Q2 2026, buying an estimated $91.5K and bringing the position to 3,997 shares worth $1.66M. The position accounts for 0.29% of the portfolio, ranked #89.

MSH Capital Advisors first reported a position in UNH in Q4 2021 and has held it in 19 quarters since. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • MSH Capital Advisors held 3,997 shares of UnitedHealth worth $1.66M as of Q2 2026.
  • MSH Capital Advisors bought 247 UnitedHealth shares in Q2 2026, an estimated $91.5K.
  • UnitedHealth made up 0.29% of MSH Capital Advisors's portfolio in Q2 2026, its #89 holding.
  • MSH Capital Advisors first reported a position in UnitedHealth in Q4 2021 and has held it in 19 quarters since.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.